Merck HPV Vaccine Dual Positioning Will Target Adolescents, Older Women
Executive Summary
Merck anticipates positioning its HPV vaccine as cervical cancer prevention both for adolescents as well as "catch-up" vaccination in older women, the company told investors during its annual business review Dec. 10